GO	[-10.07 -0.87]	[-0.87 -0.54]	[-0.54 -0.31]	[-0.31 -0.12]	[-0.12 0.00]	[0.00 0.13]	[0.13 0.32]	[0.32 0.58]	[0.58 0.79]	[0.79 1.57]	[1.57 26.69]
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP	0.325	-1.593	-1.177	-1.177	-0.606	-0.418	-1.593	-2.132	-0.279	1.697	10.905
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN	-0.381	-0.381	-1.501	-2.322	-0.977	1.960	-1.501	-0.622	0.233	0.233	7.368
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN	-0.668	-0.334	-0.668	-1.596	0.723	-0.668	-0.668	-0.668	-1.214	3.141	3.542
SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP	-0.870	-0.378	-0.378	0.236	-0.870	-0.870	-0.870	-0.378	0.527	2.038	2.722
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE	0.279	-0.787	-0.787	-0.787	-0.324	0.279	-0.787	-0.324	1.058	-0.324	3.853
